It was great collaborating with our amazing co-authors on the first publication from the scTrends Consortium. Led by Adam Cribbs, co-founder of Caeruleus Genomics, and Jake P. Taylor-King, co-founder of Relation, the paper reviews the current state of single-cell and spatial genomics technology. Relation Broad Institute of MIT and Harvard spatialist OMAPiX Single Cell Discoveries Skyhawk Therapeutics The Francis Crick Institute UCL University of Oxford KTH Royal Institute of Technology University of Cambridge Roche ARK Investment Management LLC https://lnkd.in/eTEZ_y6J
Caeruleus Genomics
Biotechnology Research
Every patient's cells have a longer story to tell | Illuminating dark RNA for precision medicine
About us
Caeruleus is a biotechnology company that decodes the hidden story of human biology beyond gene expression. Spun out from Oxford University by experts in functional genomics, target discovery and computational biology.
- Website
-
https://www.caeruleus.bio
External link for Caeruleus Genomics
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Oxford
- Type
- Privately Held
- Founded
- 2023
- Specialties
- single-cell genomics, functional genomics, machine learning, RNA biology, target discovery, and isoform discovery
Locations
-
Primary
Get directions
Oxford, GB
Employees at Caeruleus Genomics
-
Adam Cribbs
CTO of Caeruleus Genomics Group leader University of Oxford
-
Jamie Macfarlane
Creator Fund
-
Sally Sansom
HEOR Doctoral Researcher @ University of Oxford | Research Fellow @ Centre for Personalised Medicine | Clarendon Scholar
-
Louise Mackie
Strategy | FinTech | Venture Capital
Updates
-
🚀 Exploring the Future of Single-Cell and Spatial Genomics 🌍 I'm excited to share that the scTrends Consortium has just published its first report on the state of single-cell and spatial genomics technology. Led by myself and Jake P. Taylor-King at Relation, our international team has come together to review the latest trends and business developments in this rapidly evolving field. Our comment piece is now live in Nature Biotechnology. See article here: https://lnkd.in/eYmbfzT4 As technology improves, we're seeing better sensitivity and transcriptome coverage, which is crucial for understanding gene regulation and improving personalised medicine. Our team includes experts from top institutions and companies worldwide, such as the Francis Crick Institute, University College London, MIT, and many more. We've tracked the progress of various 'omics platforms, documenting key milestones like product launches and funding rounds. We're planning to release a series of articles and blog posts, with a major review coming soon. Keep an eye out for updates at scTrends. #Genomics #Biotech #DrugDiscovery #PersonalisedMedicine #scTrends #SingleCell #SpatialGenomics #HealthcareInnovation #BiomedicalResearch